Skip to main content

Table 4 Analysis of serum bilirubin, transaminase and MS at baseline with different components

From: Association of total bilirubin and indirect bilirubin content with metabolic syndrome among Kazakhs in Xinjiang

 

MS component number = 0 (n = 104)

MS component number = 1 (n = 237)

MS component number = 2 (n = 224)

HR(95%CI)

P

HR(95%CI)

P

HR(95%CI)

P

TBIL

 Q1

ref

ref

ref

ref

ref

ref

 Q2

3.80 (0.44–33.02)

0.226

0.66 (0.31–1.42)

0.284

0.35 (0.21–0.60)

< 0.001

 Q3

5.00 (0.62–40.15)

0.130

0.73 (0.35–1.56)

0.419

0.36 (0.21–0.62)

< 0.001

 Q4

3.53 (0.44–28.74)

0.238

0.67 (0.31–1.43)

0.299

0.38 (0.22–0.64)

< 0.001

IBIL

 Q1

ref

ref

ref

ref

ref

ref

 Q2

3.14 (0.35–28.55)

0.309

0.57 (0.28–1.17)

0.123

0.31 (0.18–0.54)

< 0.001

 Q3

6.81 (0.85–54.62)

0.071

0.41 (0.19–0.87)

0.020

0.39 (0.23–0.66)

< 0.001

 Q4

3.69 (0.46–29.87)

0.221

0.74 (0.39–1.41)

0.355

0.31 (0.18–0.54)

< 0.001

DBIL

 Q1

ref

ref

ref

ref

ref

ref

 Q2

0.77 (0.20–3.03)

0.707

1.29 (0.63–2.64)

0.490

1.36 (0.80–2.31)

0.254

 Q3

1.66 (0.54–5.11)

0.376

1.27 (0.59–2.70)

0.541

1.30 (0.76–2.22)

0.333

 Q4

0.31 (0.07–1.39)

0.125

1.19 (0.60–2.39)

0.618

1.03 (0.59–1.80)

0.919

ALT

 Q1

ref

ref

ref

ref

ref

ref

 Q2

0.53 (0.16–1.76)

0.301

0.88 (0.44–1.73)

0.703

1.23 (0.68–2.23)

0.502

 Q3

0.95 (0.31–2.92)

0.932

1.02 (0.51–2.06)

0.947

1.05 (0.58–1.98)

0.877

 Q4

0.47 (0.13–1.80)

0.273

0.79 (0.35–1.77)

0.564

1.24 (0.67–2.28)

0.496

AST

 Q1

ref

ref

ref

ref

ref

ref

 Q2

1.71 (0.53–5.55)

0.371

0.84 (0.42–1.68)

0.625

0.58 (0.35–0.97)

0.038

 Q3

1.59 (0.44–5.73)

0.477

0.57 (0.28–1.16)

0.119

0.67 (0.39–1.17)

0.160

 Q4

0.88 (0.19–4.08)

0.873

0.75 (0.36–1.59)

0.454

0.82 (0.47–1.44)

0.498

  1. The model with adjustment for age, sex